135 related articles for article (PubMed ID: 7622098)
41. Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer.
Filderman AE; Silvestri GA; Gatsonis C; Luthringer DJ; Honig J; Flynn SD
Am Rev Respir Dis; 1992 Sep; 146(3):707-10. PubMed ID: 1325749
[TBL] [Abstract][Full Text] [Related]
42. Age, menopausal status and DNA-content in endometrial adenocarcinoma.
Strang P; Stendahl U; Tribukait B; Wagenius G; Boman K
Anticancer Res; 1989; 9(4):1079-82. PubMed ID: 2817789
[TBL] [Abstract][Full Text] [Related]
43. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
44. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769
[TBL] [Abstract][Full Text] [Related]
45. HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma.
Pisani AL; Barbuto DA; Chen D; Ramos L; Lagasse LD; Karlan BY
Obstet Gynecol; 1995 May; 85(5 Pt 1):729-34. PubMed ID: 7724103
[TBL] [Abstract][Full Text] [Related]
46. [Ploidy in colorectal cancer].
Remvikos J; Muleris M; Vielh P; Zafrani B; Thomas G; Dutrillaux B; Girodet J; Salmon RJ
Gastroenterol Clin Biol; 1987 Oct; 11(10):681-5. PubMed ID: 3692091
[TBL] [Abstract][Full Text] [Related]
47. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
48. Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival.
Meyer JS; Lee JY
Cancer Res; 1980 Jun; 40(6):1890-6. PubMed ID: 7371021
[TBL] [Abstract][Full Text] [Related]
49. DNA ploidy, S-phase fraction and cytomorphometry in relation to survival of human penile cancer.
Yu DS; Chang SY; Ma CP
Urol Int; 1992; 48(3):265-9. PubMed ID: 1589914
[TBL] [Abstract][Full Text] [Related]
50. Relevance of DNA ploidy as a measure of genetic deviation: a comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer.
Remvikos Y; Gerbault-Seurreau M; Vielh P; Zafrani B; Magdelénat H; Dutrillaux B
Cytometry; 1988 Nov; 9(6):612-8. PubMed ID: 3208627
[TBL] [Abstract][Full Text] [Related]
51. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma.
Sorbe B; Risberg B; Frankendal B
Gynecol Oncol; 1990 Jul; 38(1):22-7. PubMed ID: 2354822
[TBL] [Abstract][Full Text] [Related]
52. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Rubens RD; Richards MA
J Clin Oncol; 1990 Dec; 8(12):2040-6. PubMed ID: 2230896
[TBL] [Abstract][Full Text] [Related]
53. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Acta Oncol; 1995; 34(6):797-802. PubMed ID: 7576748
[TBL] [Abstract][Full Text] [Related]
54. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer.
Wingren S; Stål O; Sullivan S; Brisfors A; Nordenskjöld B
Int J Cancer; 1994 Oct; 59(1):7-10. PubMed ID: 7523314
[TBL] [Abstract][Full Text] [Related]
55. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population.
Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA
Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768
[TBL] [Abstract][Full Text] [Related]
56. DNA ploidy, S-phase fraction, and G2 fraction as prognostic determinants in human pancreatic cancer.
Eskelinen M; Lipponen P; Marin S; Haapasalo H; Mäkinen K; Puittinen J; Alhava E; Nordling S
Scand J Gastroenterol; 1992; 27(1):39-43. PubMed ID: 1736340
[TBL] [Abstract][Full Text] [Related]
57. The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
Toikkanen S; Joensuu H; Klemi P
Br J Cancer; 1989 Nov; 60(5):693-700. PubMed ID: 2553094
[TBL] [Abstract][Full Text] [Related]
58. Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients.
Strang P; Stendahl U; Bergström R; Frankendal B; Tribukait B
Gynecol Oncol; 1991 Oct; 43(1):3-8. PubMed ID: 1959785
[TBL] [Abstract][Full Text] [Related]
59. [Treatment of hepatocellular carcinoma from the aspect of nuclear DNA analysis].
Fujimoto J; Okamoto E; Yamanaka N; Oriyama T; Furukawa K; Kawamura E
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1307-11. PubMed ID: 1658586
[TBL] [Abstract][Full Text] [Related]
60. DNA index, S-phase fraction, histological grade and prognosis in breast cancer.
O'Reilly SM; Camplejohn RS; Barnes DM; Millis RR; Allen D; Rubens RD; Richards MA
Br J Cancer; 1990 May; 61(5):671-4. PubMed ID: 2159768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
